NCT04092634 is a Phase 4 clinical trial of Dual mobility implant in Dislocation, Hip, sponsored by Rush University Medical Center.

Who is sponsoring NCT04092634?

NCT04092634 is sponsored by Rush University Medical Center.

What drugs are being tested in NCT04092634?

Interventions in NCT04092634: Dual mobility implant, Traditional, Single-bearing hip implant.

What condition does NCT04092634 study?

NCT04092634 studies Dislocation, Hip.

Is NCT04092634 still recruiting?

NCT04092634 is currently active, enrolled. Last updated 26 June 2025.

Last reviewed 2025-06-26 · How we verify

NCT04092634

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dual Mobility in "High Risk" Patients

Active, enrolled Phase 4 Last updated 26 June 2025

What this trial tests

Phase 4 trial testing Dual mobility implant in Dislocation, Hip in 412 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 November 2017

Primary endpoint
1 June 2025

1 February 2035

Quick facts

Lead sponsor	Rush University Medical Center
Phase	Phase 4
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	412
Start date	1 November 2017
Primary completion	1 June 2025
Estimated completion	1 February 2035
Sites	4 locations across United States

Drugs / interventions tested

Dual mobility implant
Traditional, Single-bearing hip implant

Conditions studied

Dislocation, Hip — all drugs for Dislocation, Hip →

Sponsor

Rush University Medical Center

Who can join

18 and older, any sex, with Dislocation, Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare clinical outcomes of patients considered to be high risk for prosthetic dislocation undergoing primary total hip arthroplasty (THA) with the use of a dual mobility bearing versus a conventional, single bearing design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Rush University Medical Center trials

Trials by the same sponsor.

NCT07278076 — Clinical Decision-Making During FEES: The Impact of Residue Amount and Location · NA · not yet recruiting
NCT07088120 — PRECISION-CPR: PRecision-Controlled Ventilation in CPR · NA · not yet recruiting
NCT06894719 — Oral Tranexamic Acid After Total Knee Arthroplasty · Phase 4 · not yet recruiting
NCT06229392 — A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer · Phase 1 · withdrawn
NCT07452406 — Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04092634 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rush University Medical Center
Last refreshed: 26 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04092634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing